PF-03084014 inhibits the Notch signalling pathway.
[1] It contributes totumor suppression in breast, pancreatic carcinoma,
[1] hepatocellular carcinoma
[2] and progressive desmoid tumors.
[3] PF-03084014 in combination with dexamethasone elicits antileukemic effects in T-cell acute lymphoblastic leukemias (T-ALL).
[4]